Parkinson's disease correlates with promoter methylation in the α‐synuclein gene

Abstract

Our findings support a link between SNCA variability, promoter methylation, and Parkinson's disease risk and indicate that methylation patterns in brain are mirrored in the blood. SNCA methylation warrants further investigation as a potential biomarker.